DeepHealth, a subsidiary of RadNet, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its remote scanning software, TechLive.
TechLive provides centralized operation and supervision of MRI, CT, PET/CT, and ultrasound procedures. It allows technologists to scan for multiple locations, enables improved operational efficiency, extends center operating hours, and enhances access to complex procedures, DeepHealth added. More than 300 of RadNet’s imaging systems are now connected with TechLive.
The company also highlighted a pilot deployment at 64 locations inside of RadNet’s New York area facilities. It said that TechLive contributed to a 42% decrease in MRI room closure hours during the second quarter of 2025 compared with the same period in 2024. TechLive also contributed to an increase in complex procedures, it added.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
